Bill
Bill > HB1968
TN HB1968
TN HB1968AN ACT to amend Tennessee Code Annotated, Title 20 and Title 33, relative to opioids.
summary
Introduced
01/22/2026
01/22/2026
In Committee
02/18/2026
02/18/2026
Crossed Over
Passed
Dead
Introduced Session
114th General Assembly
Bill Summary
As introduced, adds Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc. to the list of companies that may be released by the attorney general for pending or future claims regarding opioids. - Amends TCA Title 20 and Title 33.
AI Summary
This bill amends Tennessee law to add Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc. to a list of companies that the state's Attorney General can release from pending or future legal claims related to opioids, in addition to Purdue Pharma L.P. This action is being taken within the context of Tennessee Code Annotated (TCA) sections 20-13-203 and 33-11-103(p), which govern such releases. The bill also includes a standard severability clause, meaning that if any part of the act is found to be invalid, the rest of the act will still stand.
Committee Categories
Justice
Sponsors (1)
Last Action
Placed on cal. Judiciary Committee for 3/4/2026 (on 02/25/2026)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://wapp.capitol.tn.gov/apps/Billinfo/default.aspx?BillNumber=HB1968&ga=114 |
| BillText | https://www.capitol.tn.gov/Bills/114/Bill/HB1968.pdf |
| Fiscal Note - SB1495 | https://www.capitol.tn.gov/Bills/114/Fiscal/SB1495.pdf |
Loading...